Saturday 17 October 2026
Export HIND’s income statement to Excel — free account
Vyome Holdings, Inc.
HIND Healthcare Biotechnology
In the quarter to June 2026, revenue fell 46.0%, EPS grew 100.0% and free cash flow fell 195.0%, each against the same quarter a year earlier.
1.87
0.04
−2.09%
Follow HIND
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 5 | — | — | 5 | 2 | 4 | 4 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
23.25 | 0.35 | 0.18 | 0.81 | 0.00 | 451,015.58 | 2,371,432.79 | 3,767,622.90 | 104,890,153.82 | 99,162,871.79 |
Altman Z-Score |
(22.00) | (63.09) | (86.44) | (90.57) | — | 135,434.19 | 1,027,362.74 | 1,190,653.79 | 32,066,190.82 | 13,476,384.94 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(50.57) | (162.29) | (198.25) | (208.64) | (34.80) | (47.34) | (26.97) | (20.87) | (3.98) | 5.95 |
P/Operating CF |
(5.03) | (30.76) | (0.63) | (3.21) | 0.00 | (2,892,182.18) | (1,594,726.58) | (6,332,250.42) | (113,067,411.66) | (58,261,406.75) |
Beneish M-Score |
— | 17.90 | (0.23) | (14.50) | (6.74) | 4.01 | (1.68) | (4.60) | (0.02) | (2.18) |
P/B ratio |
1.98 | 0.00 | 0.23 | 2.48 | 0.00 | 351,765.38 | 490,925.04 | 2,616,093.39 | 29,615,270.27 | 5,232,246.70 |
Price to Tangible BV |
2.16 | 0.00 | 0.24 | 2.67 | 0.00 | 0.00 | 490,925.04 | 2,616,093.39 | 29,615,270.27 | 5,232,246.70 |
EV/Sales |
47.56 | 49.61 | 0.72 | 1.29 | (0.98) | 451,016.44 | 2,371,428.85 | 3,767,622.41 | 104,890,150.35 | 99,162,853.42 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(4.06) | (20.75) | (0.37) | (0.66) | 0.87 | (596,027.46) | (340,271.94) | (1,165,028.93) | (33,956,405.12) | (17,371,931.11) |
EV/FCF |
(4.06) | (20.76) | (0.37) | (0.66) | 0.85 | (570,026.26) | (337,409.28) | (1,116,400.72) | (32,838,000.14) | (17,061,843.90) |
Quick Ratio |
1.82 | 0.19 | 1.65 | 0.82 | 3.40 | 0.48 | 3.61 | 1.43 | 4.86 | 16.55 |
Current Ratio |
1.99 | 0.05 | 2.73 | 1.32 | 3.98 | 0.77 | 4.59 | 1.66 | 5.17 | 17.00 |
Net Debt/EBITDA |
0.48 | (3.53) | 0.30 | 0.09 | 0.41 | (1.07) | 0.58 | 0.38 | 1.01 | 3.43 |
Debt/Assets |
0.00% | 259.80% | 0.00% | 1.53% | 0.53% | 34.48% | 5.53% | 32.68% | 18.69% | 12.54% |
Debt/Equity |
0.00 | (0.82) | 0.00 | 0.05 | 0.01 | 0.88 | 0.07 | 0.76 | 0.28 | 0.15 |
Asset Turnover |
0.08 | 0.04 | 0.80 | 0.35 | 0.30 | 0.39 | 0.13 | 0.22 | 0.15 | 0.07 |
Operating CF/Net income |
0.37 | 0.42 | 1.49 | 0.47 | 0.24 | 0.40 | 0.97 | 0.79 | 0.88 | 0.95 |
Capex/Depreciation |
0.00 | 0.02 | (0.06) | (0.04) | (0.14) | (0.12) | (0.20) | (2.26) | (2.67) | (0.91) |
Interest Coverage |
(71.30) | (4.88) | 591.65 | (410.19) | (69.57) | (6.08) | (60.34) | (163.56) | (254.75) | (40.89) |
| 3,262.96% | (127.42%) | (220.59%) | (192.58%) | (214.71%) | (142.60%) | (163.53%) | (155.04%) | (69.94%) | (446.59%) | |
| (260.50%) | (24.04%) | (104.44%) | (145.16%) | (140.96%) | (75.30%) | (93.25%) | (89.55%) | (52.72%) | (44.02%) | |
ROIC |
0.00% | 0.00% | (456.96%) | 0.00% | (165.96%) | (32.10%) | (496.88%) | 0.00% | (3,384.94%) | 0.00% |
Return on Tangible Assets |
(373.23%) | 26.91% | (173.08%) | (1,477.43%) | (264.63%) | 1,041.41% | (154.35%) | (284.15%) | (80.68%) | (27.59%) |
Average Days of Receivables |
0.00 | 1,402.32 | 69.78 | 70.79 | 75.55 | 84.64 | 31.71 | 34.89 | 155.48 | 55.40 |
Research and Development Expense of Revenue |
184.02% | 111.09% | 26.68% | 22.57% | 17.42% | 30.96% | 210.09% | 117.54% | 107.39% | 290.95% |
Selling, General and Administrative Expense of Revenue |
739.94% | 349.79% | 205.95% | 278.85% | 244.21% | 134.71% | 508.02% | 329.04% | 290.79% | 301.12% |
Intangible Assets out of Total Assets |
0.05 | 0.23 | 0.00 | 0.02 | 0.40 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
2,057.18% | 71.62% | 8.83% | 18.57% | 89.90% | 11.71% | 90.92% | 51.57% | 32.69% | 16.59% |
Graham Net Nets |
0.36 | (61.33) | 4.07 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 34,650.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(141.04%) | (544.96%) | (718.88%) | (695.38%) | (152.20%) | (11.36%) | (33.77%) | (18.89%) | 0.00% | (5.58%) |
Free Cash Flow Yield |
(50.43%) | (688.12%) | (1,095.83%) | (242.15%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.15 | 1,284.50 | 8,678.00 | 112,400.00 | 0.00 | 2.89 | 0.70 | 4.78 | 0.59 | 0.80 |
Operating CF per Share |
(1.73) | (3,070.50) | (16,960.00) | (219,020.00) | 0.00 | (2.19) | (4.86) | (15.46) | (1.83) | (4.59) |
Capex per Share |
0.00 | 1.50 | (10.00) | (920.00) | 0.00 | (0.10) | (0.04) | (0.67) | (0.06) | (0.08) |
Free Cash Flow per Share |
(1.73) | (3,069.00) | (16,970.00) | (219,940.00) | 0.00 | (2.29) | (4.90) | (16.13) | (1.89) | (4.67) |
Cash per Share |
2.31 | 509.50 | 4,559.00 | 39,550.00 | 0.00 | 0.77 | 2.99 | 12.47 | 2.66 | 17.88 |
Shareholders Equity per Share |
1.74 | (21,955.00) | 6,663.00 | 36,610.00 | 0.00 | 3.71 | 3.37 | 6.88 | 2.10 | 15.23 |
Interest Debt per Share |
0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.74 | (21,955.00) | 6,663.00 | 36,610.00 | 0.00 | 3.71 | 3.37 | 6.88 | 2.10 | 15.23 |
Free Cash Flow |
(3.75) | (0.61) | (16.97) | (21.99) | (15.73) | (8.94) | (23.06) | (30.71) | (31.67) | (19.72) |
Working Capital |
2.70 | (5.44) | 6.52 | 2.43 | 22.41 | (2.66) | 14.26 | 11.42 | 41.74 | 73.47 |
Capital Expenditures |
— | 0.00 | (0.01) | (0.09) | (0.35) | (0.39) | (0.19) | (1.28) | (1.04) | (0.35) |
Net Current Asset Value |
2.70 | (5.47) | 6.30 | 2.43 | 21.74 | (13.63) | 13.69 | 11.37 | 33.77 | 63.59 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.06 | 0.14 | 0.11 | 0.10 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.26 | 0.29 | 2.57 | 3.08 | 1.70 | 5.76 | 0.89 | 0.33 | 0.29 | 0.54 |
Cash ROIC |
(42.87%) | 87.72% | (151.22%) | (282.45%) | (23.32%) | (29.53%) | (74.31%) | (65.67%) | (35.41%) | (13.18%) |
Accounts Receivable Turnover |
0.00 | 0.19 | 4.52 | 4.50 | 5.00 | 7.78 | 5.68 | 3.57 | 4.18 | 5.90 |
Accounts Payable Turnover |
0.09 | 0.05 | 1.73 | 1.65 | 1.47 | 2.34 | 3.27 | 4.45 | 5.16 | 4.91 |
Inventory Turnover |
0.00 | 0.02 | 0.85 | 1.34 | 2.00 | 2.41 | 1.68 | 3.62 | 4.30 | 4.72 |
Average Days of Payables |
4,654.56 | 5,684.58 | 196.96 | 158.40 | 241.02 | 264.86 | 80.18 | 78.01 | 96.45 | 77.31 |
Days of Inventory on Hand |
0.00 | 14,482.26 | 436.25 | 296.98 | 208.70 | 162.61 | 239.54 | 106.34 | 107.18 | 107.46 |
Average Receivables |
— | 1.32 | 1.92 | 2.50 | 2.72 | 1.45 | 0.58 | 2.55 | 2.37 | 0.58 |
Average Payables |
1.13 | 1.33 | 1.81 | 2.70 | 3.56 | 2.15 | 0.90 | 1.22 | 0.94 | 0.57 |
Average Inventory |
— | 3.10 | 3.68 | 3.31 | 2.62 | 2.09 | 1.76 | 1.50 | 1.12 | 0.60 |
Average Assets |
3.94 | 6.02 | 10.90 | 31.84 | 44.80 | 28.73 | 25.39 | 41.74 | 65.94 | 46.50 |
Average Common Equity |
(0.31) | 1.14 | 5.16 | 24.00 | 29.41 | 15.17 | 14.48 | 24.11 | 49.71 | 4.58 |
Columns are period end dates · fundamentals updated 1 Oct 2026